期刊
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
卷 23, 期 6, 页码 -出版社
MDPI
DOI: 10.3390/ijms23063127
关键词
trace amine-associated receptor 5; antagonist; AtomNet; BRET
资金
- Istituto Italiano di Tecnologia, Genova, Italy
- Russian Science Foundation [19-75-30008]
- Russian Science Foundation [19-75-30008] Funding Source: Russian Science Foundation
Trace amine-associated receptor 5 (TAAR5) is expressed in the olfactory epithelium and limbic brain regions, and is involved in the regulation of emotional behavior and adult neurogenesis. Two identified mTAAR5 antagonists inhibit TMA-induced cAMP production and downstream signaling.
Trace amine-associated receptor 5 (TAAR5) is a G protein-coupled receptor that belongs to the TAARs family (TAAR1-TAAR9). TAAR5 is expressed in the olfactory epithelium and is responsible for sensing 3-methylamine (TMA). However, recent studies showed that TAAR5 is also expressed in the limbic brain regions and is involved in the regulation of emotional behaviour and adult neurogenesis, suggesting that TAAR5 antagonism may represent a novel therapeutic strategy for anxiety and depression. We used the AtomNet(R) model, the first deep learning neural network for structure-based drug discovery, to identify putative TAAR5 ligands and tested them in an in vitro BRET assay. We found two mTAAR5 antagonists with low to submicromolar activity that are able to inhibit the cAMP production induced by TMA. Moreover, these two compounds also inhibited the mTAAR5 downstream signalling, such as the phosphorylation of CREB and ERK. These two hits exhibit drug-like properties and could be used to further develop more potent TAAR5 ligands with putative anxiolytic and antidepressant activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据